Sun Pharma Drug Recall
- All
- News
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Sun Pharma Recalls 31,762 Bottles Of Antidepressant In US
The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US drug regulator said.
-
Sun Pharma Recalls 16,000 Bottles Of Antidepressant Tablets In US
Drug major Sun Pharmaceutical Industries is recalling over 16,000 bottles of anti-depressant tablets from the US market due to failed dissolution specifications.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Sun Pharma Recalls 10 Lakh Boxes of Allergy Drug in US
Drug major Sun Pharma is recalling over 10 lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be 'super potent' and 'out of specification'.
-
Sun Pharma, Wockhardt Recall Drugs from US Market
According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
-
Sun Pharma Recalls 3,263 Bottles of Epilepsy Drug in US
The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.
-
Sun Pharma Recalls 68,194 Bottles of Anti-Depression Drug in US
As per the information available on the USFDA website, Sun Pharma Global Inc, a unit of the company, is recalling the drug for failing "dissolution specification".
-
Why Sun Pharma Shares are Down 8% in 4 Days
According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.
-
Sun Pharma Shares Fall 6% on Reports of FDA Inspection
The move was likely triggered by increased drug recalls from the Halol plant, analysts say. Other analysts said an inspection was due because the US regulator had last visited the Halol plant in September 2012.
-
Sun Pharma Recalls Over 40,000 Bottles of Antidepressant in US
Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.
-
Sun Pharma Recalls 200 Vials of Cancer Drug: FDA
The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.
-
Sun Pharma Recalls Over 4 Lakh Bottles of 2 Drugs in US: Report
Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.
-
Ranbaxy Recalls Nearly 30,000 Packs of Allergy-Relief Drug in US
The drugmaker started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.
-
Glenmark pulls 2,900 bottles of ulcer drug in US
In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Sun Pharma Recalls 31,762 Bottles Of Antidepressant In US
The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US drug regulator said.
-
Sun Pharma Recalls 16,000 Bottles Of Antidepressant Tablets In US
Drug major Sun Pharmaceutical Industries is recalling over 16,000 bottles of anti-depressant tablets from the US market due to failed dissolution specifications.
-
Sun Pharma Recalls 3.8 Lakh Cartons of Osteoporosis Drug in US: Report
Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".
-
Sun Pharma Recalls 10 Lakh Boxes of Allergy Drug in US
Drug major Sun Pharma is recalling over 10 lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be 'super potent' and 'out of specification'.
-
Sun Pharma, Wockhardt Recall Drugs from US Market
According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
-
Sun Pharma Recalls 3,263 Bottles of Epilepsy Drug in US
The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.
-
Sun Pharma Recalls 68,194 Bottles of Anti-Depression Drug in US
As per the information available on the USFDA website, Sun Pharma Global Inc, a unit of the company, is recalling the drug for failing "dissolution specification".
-
Why Sun Pharma Shares are Down 8% in 4 Days
According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.
-
Sun Pharma Shares Fall 6% on Reports of FDA Inspection
The move was likely triggered by increased drug recalls from the Halol plant, analysts say. Other analysts said an inspection was due because the US regulator had last visited the Halol plant in September 2012.
-
Sun Pharma Recalls Over 40,000 Bottles of Antidepressant in US
Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.
-
Sun Pharma Recalls 200 Vials of Cancer Drug: FDA
The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.
-
Sun Pharma Recalls Over 4 Lakh Bottles of 2 Drugs in US: Report
Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.
-
Ranbaxy Recalls Nearly 30,000 Packs of Allergy-Relief Drug in US
The drugmaker started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.
-
Glenmark pulls 2,900 bottles of ulcer drug in US
In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.
